Sarah Naeger1, Ryan Mutter2, Mir M Ali3, Tami Mark4, Lauren Hughey5. 1. Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Electronic address: Sarah.Naeger@samhsa.hhs.gov. 2. Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Electronic address: Ryan.mutter@samhsa.hhs.gov. 3. Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Electronic address: Mir.ali@samhsa.hhs.gov. 4. Truven Health Analytics, 7700 Old Georgetown Road, Bethesda, MD 20814. Electronic address: Tami.mark@truvenhealth.com. 5. Truven Health Analytics, 7700 Old Georgetown Road, Bethesda, MD 20814. Electronic address: lauren.hughey@truvenhealth.com.
Abstract
INTRODUCTION: Opioid misuse is a growing public health problem, and estimates show a 150% increase in opioid-related hospital stays over the last two decades. This study examined factors associated with substance use treatment engagement following a hospitalization for opioid use disorder or overdose. METHODS: This study analyzed the Truven Health Analytics MarketScan® Commercial Claims and Encounters (CCAE) database for 2010 through 2014 to study post-hospitalization substance use disorder (SUD) treatment of individuals aged 18-64 who had an inpatient admission for an opioid-use disorder or opioid overdose. Engagement in post-discharge SUD treatment was defined as having at least two unique outpatient visits within 30 days of a hospitalization. Generalized estimating equations (GEEs) with a binomial link were used to determine the factors associated with SUD treatment engagement. RESULTS: Only 17% of patients engaged in SUD treatment within 30 days of hospital discharge. A behavioral health outpatient visit prior to the SUD admission increased the odds of engaging in SUD treatment by 1.34 (CI: 1.25-1.45), an antidepressant prescription drug fill prior to the SUD admission increased the odds by 1.14 (CI: 1.07-1.21), a benzodiazepine fill prior to the SUD admission increased the odds by 1.14 (CI: 1.07-1.21), a principal diagnosis for an SUD at index admission increased the odds by 2.13 (CI: 1.97-2.30), an alcohol-related disorder diagnosis at index admission increased the odds by 3.13 (CI: 2.87-3.42), and an additional SUD diagnosis at the index admission increased the odds by 2.72 (CI: 2.48-2.98). CONCLUSIONS: We found low rates of SUD treatment engagement following hospitalizations for opioid use disorders and overdoses. Patients with prior engagements with behavioral health providers were more likely to engage in follow-up care; therefore, providers may need to focus additional efforts on patients admitted to the hospital with opioid-use disorders who do not have an existing provider relationship. Published by Elsevier Inc.
INTRODUCTION: Opioid misuse is a growing public health problem, and estimates show a 150% increase in opioid-related hospital stays over the last two decades. This study examined factors associated with substance use treatment engagement following a hospitalization for opioid use disorder or overdose. METHODS: This study analyzed the Truven Health Analytics MarketScan® Commercial Claims and Encounters (CCAE) database for 2010 through 2014 to study post-hospitalization substance use disorder (SUD) treatment of individuals aged 18-64 who had an inpatient admission for an opioid-use disorder or opioid overdose. Engagement in post-discharge SUD treatment was defined as having at least two unique outpatient visits within 30 days of a hospitalization. Generalized estimating equations (GEEs) with a binomial link were used to determine the factors associated with SUD treatment engagement. RESULTS: Only 17% of patients engaged in SUD treatment within 30 days of hospital discharge. A behavioral health outpatient visit prior to the SUD admission increased the odds of engaging in SUD treatment by 1.34 (CI: 1.25-1.45), an antidepressant prescription drug fill prior to the SUD admission increased the odds by 1.14 (CI: 1.07-1.21), a benzodiazepine fill prior to the SUD admission increased the odds by 1.14 (CI: 1.07-1.21), a principal diagnosis for an SUD at index admission increased the odds by 2.13 (CI: 1.97-2.30), an alcohol-related disorder diagnosis at index admission increased the odds by 3.13 (CI: 2.87-3.42), and an additional SUD diagnosis at the index admission increased the odds by 2.72 (CI: 2.48-2.98). CONCLUSIONS: We found low rates of SUD treatment engagement following hospitalizations for opioid use disorders and overdoses. Patients with prior engagements with behavioral health providers were more likely to engage in follow-up care; therefore, providers may need to focus additional efforts on patients admitted to the hospital with opioid-use disorders who do not have an existing provider relationship. Published by Elsevier Inc.
Entities:
Keywords:
Opioid related hospitalization; Opioid-use disorder; Patient; Post-discharge treatment
Authors: Babak Tofighi; Noelle Leonard; Peter Greco; Aboozar Hadavand; Michelle C Acosta; Joshua D Lee Journal: J Addict Med Date: 2019 Jul/Aug Impact factor: 3.702
Authors: Tae Woo Park; Marc R Larochelle; Richard Saitz; Na Wang; Dana Bernson; Alexander Y Walley Journal: Addiction Date: 2020-01-20 Impact factor: 6.526
Authors: Pooja A Lagisetty; Lewei A Lin; Dara Ganoczy; Rebecca L Haffajee; Theodore J Iwashyna; Amy S B Bohnert Journal: Med Care Date: 2019-10 Impact factor: 2.983
Authors: Noa Krawczyk; Matthew Eisenberg; Kristin E Schneider; Tom M Richards; B Casey Lyons; Kate Jackson; Lindsey Ferris; Jonathan P Weiner; Brendan Saloner Journal: Ann Emerg Med Date: 2019-09-09 Impact factor: 5.721